# Vincristine

## Vincristine inj 1mg/1mL

##### 臨採

| TAH Drug Code      | IVIN1                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Acute leukemia & for Hodgkin's disease & non-Hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma. Wilms' tumor, reticulum cell sarcoma, lymphosarcoma.                                                                                                                                                                                                                       |
| Dosing             | (Micromedex) [Acute leukemia] 1.4-2 mg/m2/week IVD. [AIDS-related Kaposi's sarcoma] 0.03-1.4 mg/m2/week. Maximum: 2 mg/m2. Dosing and frequency may vary by protocol and/or treatment phase.                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Demyelinating form of Charcot-Marie-Tooth syndrome; avoid use in patients receiving radiation therapy through ports that include the liver.                                                                                                                                                                                                                                             |
| Adverse Effects    | Neurotoxicity, hypertension & hypotension, ataxia, foot drop, depression, agitation, insomnia, hallucinations, episodes of altered consciousness, anemia, thrombocytopenia, constipation, paralytic ileus, hyperuricemia, bladder atony, alopecia, hypersecretion of ADH, fever & headache, abnormal Valsalva response, impotence. Rarely, allergic-type reactions such as anaphylaxis. |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data – Potential Toxicity(Mother)                                                                                                                                                                                                                                                                                                                                    |

